Abstract:Background The clinical importance of rheumatoid arthritis-associated interstitial lung disease has been increased because the usual interstitial pneumonia (UIP) is the most common subtype of interstitial lung disease (ILD) on high-resolution computed tomography (HRCT) in rheumatoid arthritis (RA)and has poor survival rate compared to other forms of ILD related to connective tissue disease. Objectives The clinical characteristics and laboratory data of RA patients with and without ILD were compared in order to clarify the risk factors for ILD in RA patients. Furthermore, risk factors of mortality in the RA patients with ILD group were analyzed. Methods A total of 77 RA patients with ILD and 231 age/sex-, and disease duration-matched RA patients without ILD who were followed from 1991 to 2011 at Seoul National University Hospital were enrolled in this study. Epidemiologic, clinical, and laboratory information including rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) were obtained through medical chart review. The erythrocyte sedimentation rates (ESR), C-reactive protein (CRP) levels, presence of erosion on joint X-rays, and mean corticosteroid doses were examined in order to compare RA outcomes between the RA patients with and without ILD. Cox proportional hazard models were used to estimate the risk of mortality in the RA patients with ILD. Results In the RA with ILD group, the titers of the RF and the anti-CCP were significantly higher compared with those in the RA without ILD group (p=0.001 for both). The RA patients with ILD had higher frequency of a history of tuberculosis or nontuberculous mycobacteria (NTM) (p=0.022). In addition, the RA with ILD group exhibited higher levels of CRP at the time of RA diagnosis (p=0.014) and higher ESR (p=0.022) and CRP levels (p<0.001) throughout the 10-year follow-up period. These patients received higher mean daily dose of corticosteroid (p<0.001). In the subgroup analysis of RA patients with ILD, 28 (36.4%) patients died with the mean follow-up duration of 8.7 years. Male patients, high RF titers and UIP subtype on HRCT had significantly worse survival, and those with nonspecific interstitial pneumonia (NSIP) on HRCT had better survival. In the multivariate analysis, a UIP subtype on HRCT and older age at the time of ILD diagnosis were significantly associated with mortality of RA with ILD. Conclusions The RA patients with ILD had higher RF and anti-CCP titers and baseline CRP levels compared with those without ILD. A UIP subtype on HRCT and older age at the time of the diagnosis of ILD were significantly associated with mortality of RA with ILD. Disclosure of Interest None declared

Interstitial Lung Disease of the UIP Variant as the Only Presenting Symptom of Rheumatoid Arthritis

A Case of Rheumatoid Arthritis-Associated Interstitial Lung Disease - An Unfortunate Complication of Untreated Rheumatoid Arthritis!

Interstitial Lung Disease as the Initial Manifestation of Rheumatoid Arthritis: A Case Report and Review of the Literature

Assessment of the clinical features of rheumatoid arthritis-related interstitial lung diseases: a retrospective evaluation

Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease.

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment

Rheumatoid arthritis–associated interstitial lung disease: an overview of epidemiology, pathogenesis and management

Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review

Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis

AB0356 Comparison of the Clinical Characteristics of Rheumatoid Arthritis Patients with and Without Interstitial Lung Disease

Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database

Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease

Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

Pulmonary ultrasound: Diagnostic possibilities for interstitial lung disease associated with rheumatoid arthritis

Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology

Biomarkers of rheumatoid arthritis-associated interstitial lung disease.

Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA

Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment